BahVideo.com
Total Results 593
Search Results
Prof Mathias Rummel - Klinikum der  | BahVideo.com

Prof Mathias Rummel - Klinikum der ...

0 of 5 Stars
March 01, 2011
Prof Mathias Rummel discusses his research demonstrating the efficacy of bendamustine plus rituximab as a treatment for mantle cell lymphomas (MCL). Following the results presented at ASH 2009 ...
Chair Prof Meletios Dimopoulos - Univeristy  | BahVideo.com

Chair: Prof Meletios Dimopoulos - Univeristy ...

0 of 5 Stars
March 01, 2011
The panel discuss how the results of recent clinical trials have advanced our understanding of the optimal treatment for multiple myeloma. The development of new combinations containing drugs such ...
Prof Mathias Rummel - Klinikum der  | BahVideo.com

Prof Mathias Rummel - Klinikum der ...

0 of 5 Stars
March 01, 2011
Prof Mathias Rummel talks about the history of bendamustine from its origins in 1960’s East Germany to the modern trials evaluating the use of bendamustine and rituximab to treat ...
Prof Antonio Palumbo - Molinette Hospital  | BahVideo.com

Prof Antonio Palumbo - Molinette Hospital, ...

0 of 5 Stars
March 01, 2011
Prof Antonio Palumbo and Prof Vincent Rajkumar discuss some of the key research into myeloma that was presented at ASH 2010. This includes trials demonstrating that post transplant lenalidomide ...
Prof Anton Hagenbeek - Academic Medical  | BahVideo.com

Prof Anton Hagenbeek - Academic Medical ...

0 of 5 Stars
February 23, 2011
Prof Anton Hagenbeek discusses the five and a half year results of the First-Line Indolent Trial (FIT) study. The randomised phase III FIT study evaluates the clinical benefits and safety of a ...
Prof Valeria Santini - University of Florence  | BahVideo.com

Prof Valeria Santini - University of Florence, ...

0 of 5 Stars
February 21, 2011
Prof Valeria Santini talks about the results of her research on the use of comorbidity indexes to determine prognosis for elderly myelodysplastic syndrome patients treated with azacitidine. This ...
Prof Giuseppe Saglio - University of Turin  | BahVideo.com

Prof Giuseppe Saglio - University of Turin, ...

0 of 5 Stars
February 21, 2011
The groundbreaking introduction of the tyrosine kinase inhibitor (TKI) imatinib as a treatment for chronic myeloid leukaemia (CML) has been followed by the introduction of further second and third ...
Prof George Canellos - Harvard Medical School  | BahVideo.com

Prof George Canellos - Harvard Medical School, ...

0 of 5 Stars
February 21, 2011
Prof George Canellos talks about the key research that has emerged from the 2010 ASH meeting in Florida. One trial of note compared the Stanford V treatment regimen with ABVD for patients with ...
Prof Timothy Hughes - Institute of Medical and  | BahVideo.com

Prof Timothy Hughes - Institute of Medical and ...

0 of 5 Stars
February 18, 2011
Prof Timothy Hughes speaks to ecancer.tv about the ENESTnd trial which is evaluating the efficacy and safety of the second generation tyrosine kinase inhibitor nilotinib in newly diagnosed chronic ...
Dr Reinhard Stauder - Innsbruck Medical  | BahVideo.com

Dr Reinhard Stauder - Innsbruck Medical ...

0 of 5 Stars
February 18, 2011
Dr Reinhard Stauder speaks about his aims for the upcoming ecancer meeting on haematological cancers in elderly patients, Rome, 18-20th March 2011. This meeting will address the difficulties ...
Dr Michael Keating- MD Anderson Cancer Center  | BahVideo.com

Dr Michael Keating- MD Anderson Cancer Center, ...

0 of 5 Stars
February 18, 2011
Dr Michael Keating discusses his pick of the research presented at ASH 2010. This includes trials looking at new tyrosine kinase inhibitors that target LIM-kinase, Syk, PI 3-kinase delta or BTK. ...
Prof Kanti Rai - Long Island Jewish Medical  | BahVideo.com

Prof Kanti Rai - Long Island Jewish Medical ...

0 of 5 Stars
February 18, 2011
Prof Kanti Rai discusses advances that have been made in the treatment of chronic lymphocytic leukaemia (CLL). Key research presented at this years ASH congress has demonstrated that previously ...
Prof Pieter Sonneveld - Erasmus University  | BahVideo.com

Prof Pieter Sonneveld - Erasmus University ...

0 of 5 Stars
February 18, 2011
Prof Pieter Sonneveld speaks about a trial evaluating the efficacy of bortezomib during induction and maintenance therapy on progression-free survival in patients with multiple myeloma. A higher ...
Prof Wyndham Wilson - National Cancer  | BahVideo.com

Prof Wyndham Wilson - National Cancer ...

0 of 5 Stars
February 18, 2011
Prof Wyndham Wilson provides a comprehensive summary of the key lymphoma related research presented at the 2010 ASH congress in Florida. The first study discussed demonstrates that treating ...
Dr William Matsui - Sidney Kimmel  | BahVideo.com

Dr William Matsui - Sidney Kimmel ...

0 of 5 Stars
February 18, 2011
Dr William Matsui speaks about plasma cell biology and how this affects cancer growth. In multiple myeloma, malignant plasma cells make up the vast majority of tumour cells and are thought to be ...
Jan Geissler - Co-Founder CML Advocates Network | BahVideo.com

Jan Geissler - Co-Founder, CML Advocates Network

0 of 5 Stars
February 18, 2011
Jan Geissler speaks about some of the key research into chronic myeloid leukaemia (CML) that has been presented at ASH 2010. This includes papers on the second generation tyrosine kinase ...
Jan Geissler - Co-Founder CML Advocates Network | BahVideo.com

Jan Geissler - Co-Founder, CML Advocates Network

0 of 5 Stars
February 18, 2011
Jan Geissler speaks about the upcoming ecancer meeting on haematological cancers in the elderly which will be held in Rome, 18-20th March 2011. This meeting will tackle issues such as the ...
Dr Jerald Radich - Fred Hutchinson Cancer  | BahVideo.com

Dr Jerald Radich - Fred Hutchinson Cancer ...

0 of 5 Stars
February 18, 2011
Dr Jerald Radich speaks about the treatment options that are available for chronic myeloid leukaemia (CML). Tyrosine kinase inhibitors such as imatinib dasatinib and erlotinib have allowed to ...
Prof Stephen Baylin - Johns Hopkins  | BahVideo.com

Prof Stephen Baylin - Johns Hopkins ...

0 of 5 Stars
February 18, 2011
Prof Stephen Baylin speaks to ecancertv about epigenetics. He explains what epigenetics is, how it is being used to treat cancer and how it may potentially be used in the future. Prof Baylin ...
Prof Giuseppe Saglio - University of Turin Italy | BahVideo.com

Prof Giuseppe Saglio - University of Turin, Italy

0 of 5 Stars
February 18, 2011
Prof Giuseppe Saglio speaks about the DASISION trial which compares dasatinib with imatinib as initial treatment for patients with newly diagnosed chronic myeloid leukaemia in chronic phase ...
: advertisement :
Featured
Content
Featuring websites that enhance the internet user’s experience.

Like
Like